Daniel Carlat, MD. Medical Director of Inpatient Psychiatry/Chairman of Psychiatry at Melrose Wakefield Healthcare. Publisher, Carlat Publishing.
Dr. Carlat has no financial relationships with companies related to this material.
Sarah K. Rivelli, MD, FACP, FAPA. System Director, Consult Liaison, Department of Psychiatry and Behavioral Medicine, Carilion Clinic. Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.
The authors have no financial relationships with companies related to this material.
Rushaniya Khairova, MD, PhD. Dr. Khairova has no financial relationships with companies related to this material.
Marianne E. Silva, LCSW. Senior Clinical Social Worker, U.S. Department of Veterans Affairs.
Ms. Silva has no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
